Item 2.02. Results of Operations and Financial Condition.
On October 26, 2012, Ventas, Inc. (the "Company") issued a press release
announcing its results of operations for the quarter ended September 30, 2012. A
copy of the press release is furnished herewith as Exhibit 99.1 and incorporated
in this Item 2.02 by reference.
The press release states that the Company's normalized funds from operations
("FFO") for the quarter ended September 30, 2012 were $284.9 million, or $0.96
per diluted common share, as compared to $255.1 million, or $0.88 per diluted
common share, for the quarter ended September 30, 2011. FFO, as defined by the
National Association of Real Estate Investment Trusts ("NAREIT"), for the
quarter ended September 30, 2012 was $289.7 million, or $0.97 per diluted common
share, as compared to $264.2 million, or $0.91 per diluted common share, for the
quarter ended September 30, 2011. The Company's net income attributable to
common stockholders for the third quarter of 2012 was $111.9 million, or $0.38
per diluted common share (including expense associated with discontinued
operations of $3.4 million), as compared to $102.9 million, or $0.35 per diluted
common share (including expense associated with discontinued operations of $0.2
million and net litigation proceeds of $85.3 million), for the comparable period
in 2011.
For the nine months ended September 30, 2012, the Company's normalized FFO was
$826.6 million, or $2.82 per diluted common share, as compared to $517.6
million, or $2.45 per diluted common share, for the nine months ended September
30, 2011. NAREIT FFO for the nine months ended September 30, 2012 was $740.6
million, or $2.52 per diluted common share, as compared to $465.8 million, or
$2.21 per diluted common share, for the nine months ended September 30,
2011. The Company's net income attributable to common stockholders for the first
nine months of 2012 was $276.5 million, or $0.94 per diluted common share
(including discontinued operations of $69.6 million), as compared to $171.5
million, or $0.81 per diluted common share (including discontinued operations of
$2.0 million and net litigation proceeds of $85.3 million), for the comparable
period in 2011.
The press release also states that the Company currently expects its normalized
FFO for the year ending December 31, 2012 to be between $3.76 and $3.78 per
diluted common share. The Company expects its net income attributable to common
stockholders for 2012 to be between $1.19 and $1.31 per diluted common share.
FORWARD-LOOKING STATEMENTS
This Current Report on Form 8-K includes "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. All statements regarding
the Company's or its tenants', operators', managers' or borrowers' expected
future financial condition, results of operations, cash flows, funds from
operations, dividends and dividend plans, financing opportunities and plans,
capital markets transactions, business strategy, budgets, projected costs,
operating metrics, capital expenditures, competitive positions, acquisitions,
investment opportunities, dispositions, merger integration, growth
opportunities, expected lease income, continued qualification as a real estate
investment trust ("REIT"), plans and objectives of management for future
operations and statements that include words such as "anticipate," "if,"
"believe," "plan," "estimate," "expect," "intend," "may," "could," "should,"
"will" and other similar expressions are forward-looking statements. These
forward-looking statements are inherently uncertain, and actual results may
differ from the Company's expectations. The Company does not undertake a duty to
update these forward-looking statements, which speak only as of the date on
which they are made.
The Company's actual future results and trends may differ materially from
expectations depending on a variety of factors discussed in the Company's
filings with the Securities and Exchange Commission. These factors include
without limitation: (a) the ability and willingness of the Company's tenants,
operators, borrowers, managers and other third parties to satisfy their
obligations under their respective contractual arrangements with the Company,
including, in some cases, their obligations to indemnify, defend and hold
harmless the Company from and against various claims, litigation and
liabilities; (b) the ability of the Company's tenants, operators, borrowers and
managers to maintain the financial strength and liquidity necessary to satisfy
their respective obligations and liabilities to third parties, including without
limitation obligations under their existing credit facilities and other
indebtedness; (c) the Company's success in implementing its business strategy
and the Company's ability to identify, underwrite, finance, consummate and
integrate diversifying acquisitions and investments, including investments in
different asset types and outside the United States; (d) macroeconomic
conditions such as a disruption of or lack of access to the capital markets,
changes in the debt rating on U.S. government securities, default or delay in
payment by the United States of its obligations, and changes in the federal
budget resulting in the reduction or nonpayment of Medicare or Medicaid
reimbursement rates; (e) the nature and extent of future competition; (f) the
extent of future or pending healthcare reform and regulation, including cost
containment measures and changes in reimbursement policies, procedures and
rates; (g) increases in the Company's borrowing costs as a result of changes in
interest rates and other factors; (h) the ability of the Company's operators and
managers, as applicable, to comply with laws, rules and regulations in the
operation of the Company's properties, to deliver high quality services, to
attract and retain qualified personnel and to attract residents and patients;
(i) changes in general economic conditions or economic conditions in the markets
in which the Company may, from time to time, compete, and the effect of those
changes on the Company's revenues, earnings and funding sources; (j) the
Company's ability to pay down, refinance, restructure or extend its indebtedness
as it becomes due; (k) the Company's ability and willingness to maintain its
qualification as a REIT in light of economic, market, legal, tax and other
considerations; (l) final determination of the Company's taxable net income for
the year ending December 31, 2012; (m) the ability and willingness of the
Company's tenants to renew their leases with the Company upon expiration of the
leases, the Company's ability to reposition its properties on the same or better
terms in the event of nonrenewal or in the event the Company exercises its right
to replace an existing tenant, and obligations, including indemnification
obligations, the Company may incur in connection with the replacement of an
existing tenant; (n) risks associated with the Company's senior living operating
portfolio, such as factors that can cause volatility in the Company's operating
income and earnings generated by those properties, including without limitation
national and regional economic conditions, costs of food, materials, energy,
labor and services, employee benefit costs, insurance costs and professional and
general liability claims, and the timely delivery of accurate property-level
financial results for those properties; (o) changes in U.S. and Canadian
currency exchange rates; (p) year-over-year changes in the Consumer Price Index
and the effect of those changes on the rent escalators contained in the
Company's leases, including the rent escalator for Master Lease 2 with Kindred
Healthcare, Inc., and the Company's earnings; (q) merger and acquisition
activity in the healthcare industry resulting in a change of control of one or
more of the Company's tenants, operators, borrowers or managers or significant
changes in the senior management of the Company's tenants, operators, borrowers
or managers; (r) the Company's ability and the ability of its tenants,
operators, borrowers and managers to obtain and maintain adequate property,
liability and other insurance from reputable, financially stable providers; (s)
the impact of increased operating costs and uninsured professional liability
claims on the liquidity, financial condition and results of operations of the
Company's tenants, operators, borrowers and managers, and the ability of the
Company's tenants, operators, borrowers and managers to accurately estimate the
magnitude of those claims; (t) risks associated with the Company's medical
office building ("MOB") portfolio and operations, including its ability to
successfully design, develop and manage MOBs, to accurately estimate its costs
in fixed fee-for-service projects and to retain key personnel; (u) the ability
of the hospitals on or near whose campuses the Company's MOBs are located and
their affiliated health systems to remain competitive and financially viable and
to attract physicians and physician groups; (v) the Company's ability to build,
maintain and expand its relationships with existing and prospective hospital and
health system clients; (w) risks associated with the Company's investments in
joint ventures and unconsolidated entities, including its lack of sole
decision-making authority and its reliance on its joint venture partners'
financial condition; (x) the impact of market or issuer events on the liquidity
or value of the Company's investments in marketable securities; and (y) the
impact of litigation or any financial, accounting, legal or regulatory issues
that may affect the Company or its tenants, operators, borrowers or managers.
Many of these factors are beyond the control of the Company and its management.